Advertisement
Advertisement

MGX

MGX logo

Metagenomi Therapeutics, Inc. Common Stock

1.23
USD
Sponsored
-0.01
-0.81%
Aug 07, 14:44 UTC -4
Closed
exchange

After-Market

1.22

-0.01
-1.14%

Metagenomi Therapeutics, Inc. Common Stock Profile

About

Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif.

Info & Links

CEO

Jian Irish

Headquarters

5959 HORTON STREET, 7TH FLOOR
EMERYVILLE, CA 94608, UNITED STATES

Industry

Medical Generic Drugs

Sector

Medical

Website

https://metagenomi.co

Auditor

PricewaterhouseCoopers LLP

Share holders

37,620,530

Employees

119

Metagenomi Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

45.78M

Enterprise Value

20.47M

Enterprise Value/EBITDA(ttm)

-0.23

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.09

Price to Book(mrq)

0.34

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-384.61%

Profit Margin(ttm)

-723.26%

Return on Equity(ttm)

-51.23%

Return on Invested Capital(ttm)

-52.53%

Return on Assets(ttm)

-36.62%

Income Statement

Revenue(ttm)

22.33M

Revenue Per Share(ttm)

0.59

Gross Profit(ttm)

22.33M

EBITDA(ttm)3

-90.03M

Net Income Available to Common(ttm)

-85.89M

Diluted EPS(ttm)

-2.30

Share Statistics

Beta (5Y Monthly)

0.66

52-Week Change

-35.94%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

37.65M

Dividend Yield

0.00%

Float4

32.94M

% Held by Insiders

12.50%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

140.16M

Total Cash Per Share(mrq)

3.72

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.43%

Quick Ratio(mrq)

6.43%

Book Value Per Share(mrq)

3.66

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.56

Free Cash Flow(ytd)

-21.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement